22q11.2 Deletion Syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder, arising chiefly from de novo non-homologous meiotic recombination events. This condition presents with a ...

22q11.2 deletion syndrome (22q11.2DS) is the most common chromosomal microdeletion disorder, estimated to result mainly from de novo non-homologous meiotic recombination events occurring in ...

Researchers have identified a promising strategy to improve memory and brain cell function in models of 22q11.2 Deletion Syndrome. The study, published in eLife, shows that reducing the levels of the ...

Interneurons are thought to be a primary pathogenic target for several behavioral disorders that arise during development including schizophrenia and autism. It is not known, however, whether genetic ...

The efficacy and safety of Zygel is being evaluated in the INSPIRE study. The Food and Drug Administration (FDA) has granted Orphan Drug designation to Zygel™ (cannabidiol gel; Zynerba Pharmaceuticals ...